US Stem Cell Inc (USRM)

[Poor Man -]

Too Many Gimmicks.

Name changes, small insider buys, reverse splits can't mask massive operating losses and on-going dilution without end.

The management of Bioheart (all two of them) are just not making serious decision and instead rely on gimmicks to manipulate the stock price. Maybe some unknowing sop will see U.S Stem Cell and just based on the name thinks "Wow, I found a major stem cell company!' But not that many people are so gullible (other than a couple of insiders) to make a difference.

The only one benefitting from these gimmicks will be the market makers and the hedge funds that buy shares at heavy discounts and sell them back to you at a mark up.

What an awful company.